Results 201 to 210 of about 355,372 (304)
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar+10 more
wiley +1 more source
Administration of Ascorbic Acid Alleviates Neuronal Damage After Cerebral Ischemia in ODS Rats. [PDF]
Iwata N+9 more
europepmc +1 more source
Neonatal seizures: Advances in diagnosis and management
Abstract The International League Against Epilepsy (ILAE) created the ILAE Neonatal Task Force that classified neonatal seizures, defined neonatal epilepsy syndromes, and specified treatment guidelines. These frameworks, in addition to improved access to genetic testing and other recent advances, have revolutionized the diagnosis and management of ...
Elissa G. Yozawitz+2 more
wiley +1 more source
Targeting oxidative stress and metal imbalance in cerebral ischemia: the neuroprotective role of sodium valproate. [PDF]
Ulaş M+2 more
europepmc +1 more source
Abstract Objective Late‐onset epilepsy of unknown etiology (LOEU) carries an elevated risk of dementia, suggesting that it may represent an early manifestation of neurodegenerative or cerebrovascular disease. Direct comparisons between LOEU and acquired lesional late‐onset epilepsy (LOE) may elucidate clinical features specific to LOEU.
L. Brian Hickman+9 more
wiley +1 more source
Morphometry of Intracranial Carotid Artery Calcifications in Patients with Recent Cerebral Ischemia. [PDF]
Berghout BP+11 more
europepmc +1 more source
The multiple hit model of infantile and epileptic spasms: The 2025 update
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou+6 more
wiley +1 more source
Neuroprotective effect of riboflavin kinase on cerebral ischemia injury in rats. [PDF]
Zou Y+6 more
europepmc +1 more source
Protecting neuronal mitochondria by eliminating the mitochondrial ROS (mtROS) storm is crucial to abrogate the neuronal damage cascade of ischemic stroke ischemia reperfusion (ISIR), which is a long‐standing challenge in the field of ischemic stroke (IS).
Xiaojing Shi+15 more
wiley +1 more source
Cerebral Ischemia and Hemorheology [PDF]
openaire +2 more sources